PCSK9 Competitive Grant Program
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit:
Memorial Deadline: Inquire with RGCS
External Deadline: Friday 11th, May 2018
Description
The PCSK9 Competitive Grant Program aims to advance the science of PCSK9, especially at the junction with atherosclerosis and atherosclerosis-related mechanisms.
Specific scientific areas of research eligible for a PCSK9 Competitive Grant Program award include:
- – Interaction between PCSK9 and lipoprotein and remnant particle
- – PCSK9 and non-low-density lipoprotein receptor effects
- – PCSK9 and immune function
- – Effects of PCSK9 on vascular wall biology through genetic, proteomic, and metabolic studies
- – Lipid kinetics and PCSK9 in patients with familial hypercholesterolemia, metabolic syndrome, or diabetes
- – PCSK9 homeostasis
- – PCSK9 and pancreatic β cells
- – PCSK9 and neurocognition
- – Other potential areas of PCSK9 research that are not out of scope.
The Program will provide an opportunity for investigators from around the world to compete for individual grants of up to 200,000 USD for novel research proposals that seek to advance the understanding of PCSK9 and atherosclerosis.
The program is global in reach and is open to proposals from established and junior investigators*.
The deadline for applications is Friday, May 11, 2018 (11:59 pm US Pacific Time).
*Junior investigators should be within 5 years of completion of training
Visit the website https://www.amgenscientificgrants.com/pcsk9/ for further details of the scientific scope of the program, applicant eligibility criteria, and the application process.